GetTopicDetailResponse(id=75938e15e4, topicName=HER-2陽性, introduction=HER-2陽性, content=null, image=null, comments=1, allHits=1164, url=https://h5.medsci.cn/topic?id=8715, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=5742, tagList=[TagDto(tagId=5742, tagName=HER-2陽性)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2213653, encodeId=957822136533a, content=<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a> <a href='/topic/show?id=75938e15e4' target=_blank style='color:#2F92EE;'>#HER-2陽性#</a>, objectTitle=讀書報(bào)告 | Her-2陽性進(jìn)展期乳腺癌的治療現(xiàn)狀及展望, objectType=article, longId=832840, objectId=98698328406f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240703/1719991318360_8538692.jpg, objectUrl=/article/show_article.do?id=98698328406f, replyNumber=0, likeNumber=135, createdTime=2024-07-06, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=98698328406f, moduleTitle=讀書報(bào)告 | Her-2陽性進(jìn)展期乳腺癌的治療現(xiàn)狀及展望, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=98698328406f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=601713, encodeId=5fdd601e1309, content=<a href='/topic/show?id=75938e15e4' target=_blank style='color:#2F92EE;'>#HER-2陽性#</a>陽性率有多高？, objectTitle=Lancet Oncol：派姆單抗聯(lián)合療法一線治療HER2陽性轉(zhuǎn)移性食管胃癌, objectType=article, longId=194729, objectId=8973194e294c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020525/1590405529075_2051781.jpg, objectUrl=/article/show_article.do?id=8973194e294c, replyNumber=0, likeNumber=136, createdTime=2020-06-07, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8973194e294c, moduleTitle=Lancet Oncol：派姆單抗聯(lián)合療法一線治療HER2陽性轉(zhuǎn)移性食管胃癌, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=8973194e294c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
